Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Alladapt Immunotherapeutics

OIT Drug That Treats 15 Food Allergies Increased Eliciting Threshold but...

FDA Fast Tracks Alladapt’s ADP101 for the Treatment of Single and...

Alladapt’s Multi-Allergen OIT Candidate Shows Promise in Clinical Study

Alladapt Announces Positive Results for Multi-Allergen OIT Candidate from Phase 1/2...

Alladapt’s 15-Allergen OIT Candidate Ready to Begin Phase 1/2 Study

Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...

Broad Spectrum OIT Candidate for Multiple Food Allergies Begins Phase 1/2...

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

Your School On Our Map

Put Your School on the Map